keyword
MENU ▼
Read by QxMD icon Read
search

Esquizofrenia

keyword
https://www.readbyqxmd.com/read/26834967/nurses-perceptions-of-medication-adherence-in-schizophrenia-results-of-the-adhes-cross-sectional-questionnaire-survey
#1
Robin Emsley, Koksal Alptekin, Jean-Michel Azorin, Fernando Cañas, Vincent Dubois, Philip Gorwood, Peter M Haddad, Dieter Naber, José Manuel Olivares, Georgios Papageorgiou, Miguel Roca, Pierre Thomas, Ludger Hargarter, Andreas Schreiner
OBJECTIVES: Poor adherence to antipsychotic treatment is a widespread problem within schizophrenia therapy with serious consequences including increased risks of relapse and rehospitalization. Mounting evidence supports the key roles that nurses play in monitoring patient progress and facilitating long-term treatment adherence. The Adherencia Terapéutica en la Esquizofrenia (ADHES) nurses' survey was designed to assess the opinions of nurses on the causes and management of partial/nonadherence to antipsychotic medication...
December 2015: Therapeutic Advances in Psychopharmacology
https://www.readbyqxmd.com/read/25944551/schizophrenia-through-the-carers-eyes-results-of-a-european-cross-sectional-survey
#2
A Svettini, B Johnson, C Magro, J Saunders, K Jones, S Silk, L Hargarter, A Schreiner
Schizophrenia is a serious mental disorder affecting approximately 29 million people worldwide. The ideal treatment and care of patients with schizophrenia should be provided by a multidisciplinary 'team' involving psychiatrists, nurses and other healthcare professionals, together with carers and patients. In light of the key role carers play in the care of patients with schizophrenia, the present survey was designed to assess the opinions of family members and friends of patients with schizophrenia across Europe and to ascertain their attitudes towards the illness, medication and adherence to medication...
September 2015: Journal of Psychiatric and Mental Health Nursing
https://www.readbyqxmd.com/read/25004184/double-blind-placebo-controlled-study-of-the-efficacy-of-reboxetine-and-citalopram-as-adjuncts-to-atypical-antipsychotics-for-negative-symptoms-of-schizophrenia
#3
RANDOMIZED CONTROLLED TRIAL
Judith Usall, Raquel López-Carrilero, Raquel Iniesta, Mercedes Roca, Montserrat Caballero, Roberto Rodriguez-Jimenez, Cristina Oliveira, Miguel Bernardo, Iluminada Corripio, Santiago Durán Sindreu, Jose Carlos González Piqueras, Ana Espliego Felipe, Blanca Fernandez de Corres, Angela Ibáñez, Raúl Huerta
OBJECTIVE: In this study, we assessed the efficacy of 2 pharmacodynamically different antidepressants, citalopram (a selective serotonin reuptake inhibitor) and reboxetine (a norepinephrine reuptake inhibitor), as adjunctive therapy to risperidone and olanzapine for the treatment of negative symptoms in schizophrenia. METHOD: We performed a 6-month, multicenter, double-blind, randomized, placebo-controlled clinical trial. The recruitment period was from November 2008 to December 2011...
June 2014: Journal of Clinical Psychiatry
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"